This adds to reported immunosuppressive mechanisms of prostaglandins such as the induction of myeloid-derived suppressor cells through COX2-2/PGE2.16, 52 This provides a rationale for therapeutic targeting of COX-2 expression and stress-induced prostaglandin synthesis to boost immune surveillance and immunotherapy of cancer. Here, PTGS2 is linked to cancer.